A Clinical Trial Authorization Agreement (CTA) is a formal authorization document that permits initiation of a clinical trial under defined regulatory and contractual conditions.
CTAs document required approvals, responsibilities, and obligations before study activities begin. They support alignment among sponsors, institutions, and oversight bodies on compliance expectations. Clear authorization reduces startup risk and improves accountability across study stakeholders. Proper CTA governance supports participant protection and regulatory defensibility throughout the study lifecycle.